Published • loading... • Updated
Chong Kun Dang Expands Global Push with New Drugs
Summary by businesskorea.co.kr
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Chong Kun Dang Expands Global Push with New Drugs
Chong Kun Dang Chairman Lee Jang-han (Photo provided by Chong Kun Dang) Chong Kun Dang is accelerating its push into global markets on the back of steady research and development investment and new drug development. The company is expanding clinical trials across a range of fields, including anticancer drugs, biosimilars, and innovative new medicines based on antibody-drug conjugates, or ADCs. According to the Financial Supervisory Service’s ele…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
